U.S Physical Therapy Shares Outstanding 2010-2023 | USPH

U.S Physical Therapy shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
U.S Physical Therapy Annual Shares Outstanding
(Millions of Shares)
2023 14
2022 13
2021 13
2020 13
2019 13
2018 13
2017 13
2016 13
2015 12
2014 12
2013 12
2012 12
2011 12
2010 12
2009 12
U.S Physical Therapy Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 14
2023-09-30 15
2023-06-30 14
2023-03-31 13
2022-12-31 13
2022-09-30 13
2022-06-30 13
2022-03-31 13
2021-12-31 13
2021-09-30 13
2021-06-30 13
2021-03-31 13
2020-12-31 13
2020-09-30 13
2020-06-30 13
2020-03-31 13
2019-12-31 13
2019-09-30 13
2019-06-30 13
2019-03-31 13
2018-12-31 13
2018-09-30 13
2018-06-30 13
2018-03-31 13
2017-12-31 13
2017-09-30 13
2017-06-30 13
2017-03-31 13
2016-12-31 13
2016-09-30 13
2016-06-30 13
2016-03-31 12
2015-12-31 12
2015-09-30 12
2015-06-30 12
2015-03-31 12
2014-12-31 12
2014-09-30 12
2014-06-30 12
2014-03-31 12
2013-12-31 12
2013-09-30 12
2013-06-30 12
2013-03-31 12
2012-12-31 12
2012-09-30 12
2012-06-30 12
2012-03-31 12
2011-12-31 12
2011-09-30 12
2011-06-30 12
2011-03-31 12
2010-12-31 12
2010-09-30 12
2010-06-30 12
2010-03-31 12
2009-12-31 12
2009-09-30 12
2009-06-30 12
2009-03-31 12
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.506B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.532B 10.00
Quest Diagnostics (DGX) United States $14.447B 14.94
DaVita (DVA) United States $11.622B 15.81
Chemed (CHE) United States $9.137B 28.75
Encompass Health (EHC) United States $8.044B 22.07
Elanco Animal Health (ELAN) United States $6.389B 14.53
Option Care Health (OPCH) United States $5.286B 20.69
RadNet (RDNT) United States $3.263B 95.30
Amedisys (AMED) United States $2.981B 21.27
LifeStance Health (LFST) United States $2.235B 0.00
Astrana Health (ASTH) United States $2.075B 26.17
Addus HomeCare (ADUS) United States $1.517B 23.26
Pennant (PNTG) United States $0.626B 36.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.310B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.030B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00